ENDEFR
Home › Netherlands › Alphatron Medical Innovations B.V.

Alphatron Medical Innovations B.V.

besloten vennootschap met beperkte aansprakelijkheid (BV) · Rotterdam, Netherlands · LEI 724500SUSXZ9CB7BH627
LEI active

Summary

Alphatron Medical Innovations B.V. is registered in the Netherlands and entered in the “Business Register (KvK)” under number 52371433. Its legal form is besloten vennootschap met beperkte aansprakelijkheid (BV) – private limited company (Netherlands). According to GLEIF, its ultimate parent is Alphatron Holding B.V. (Netherlands), which is also its direct parent. That group has 8 subsidiaries with LEIs in 1 country, 8 of them in the Netherlands. The LEI was first issued on 17 Nov 2014 and the record was last updated on 17 Nov 2025; the next renewal is due by 17 Nov 2026. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2023, more than 24 months before this data release. The group may have changed since.

Company details

Legal formbesloten vennootschap met beperkte aansprakelijkheid (BV)
private limited company (Netherlands)
RegisterBusiness Register (KvK) · Register website
Registration number52371433
Registration authorityThe Netherlands Chamber of Commerce
JurisdictionNetherlands
Registered addressFairoaksbaan 192, 3045AS Rotterdam, Netherlands
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)22 Mar 2011
LEI724500SUSXZ9CB7BH627
LEI statusactive
LEI first issued17 Nov 2014
LEI record last updated17 Nov 2025
Next LEI renewal17 Nov 2026
Corroboration of the LEI recordfully corroborated

Group membership

Alphatron Holding B.V. Netherlands ultimate parent
Alphatron Medical Innovations B.V. this entity
View the whole group: 8 subsidiaries in 1 countries

Relationship to the parent

Direct parentUltimate parent
ParentAlphatron Holding B.V.Alphatron Holding B.V.
Accounting period1 Jan 2023 to 31 Dec 20231 Jan 2023 to 31 Dec 2023
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardother standardother standard
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start24 Apr 201724 Apr 2017
Recorded at GLEIF since18 Feb 202125 Jul 2018
Last updated17 Nov 202517 Nov 2025
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (7)